NEW Blog Post - Advancing CAR-NK Therapy: Why Leukopak Quality and Donor Characterization Matter Discovery Partners with PathAI to Develop First AI-Powered Biospecimen Solutions NEW Blog Post - Overcoming In Vitro Liver Metabolism Screening Limitations with Permeabilized Human Hepatocytes

NEW Blog Post - Advancing CAR-NK Therapy: Why Leukopak Quality and Donor Characterization Matter Discovery Partners with PathAI to Develop First AI-Powered Biospecimen Solutions NEW Blog Post - Overcoming In Vitro Liver Metabolism Screening Limitations with Permeabilized Human Hepatocytes

ASMS 2023 – Unleashing the Power of Proteomics

See inside Discovery Life Sciences’ Proteomics Services Lab:

Biomarker discovery and validation
Mechanism of action studies
Phenotypic screening
Post-translational modification
Protein complex analysis

Privacy Settings